The moral imperative: Balancing innovation, regulation and prescription drug availability

At the Intersection of Science and Law

English - March 21, 2022 17:34 - 30 minutes - 28 MB
Life Sciences Science Technology covid19 fda mrna pfizer dlapiper law lawfirms legal pandemic vaccine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Incentivizing diverse representation in clinical trials

Next Episode: Advising the advisor: Tips for navigating the life sciences and regulatory environment

DLA Piper's Jim Greenwood and Geoff Levitt are joined by Peter Kolchinsky, founding Partner and Portfolio Manager at RA Capital, to discuss the importance of – and complications in – balancing biopharmaceutical innovation, industry regulations and prescription drug availability.

See omnystudio.com/listener for privacy information.